Financials Subsidiary Financials

Sequent Research Limited

Sequent Anti Biotics Private Limited

Sequent Pharmaceuticals Private Limited

Sequent Penems Private Limited

Elysian Life Sciences Private Limited

Alivira Animal Health Limited

Naari Pharma Private Limited (Indo Phyto Chemicals Private Limited)

Share holding pattern Annual reports Directors Report Corporate Governance Share price Unclaimed Dividend Notices Result Code of Conduct and Ethics Policies
Whistle Blower Policy

The Board of Directors at its meeting held on May 28, 2014 had approved the Whistle Blower Policy namely “Sequent Whistle Blower Policy”. The Company has implemented this policy throughout the Company for providing a mechanism for personnel to report to the Authority concerns about unethical behavior, actual or suspected fraud or violation of the company’s code of conduct or ethics policy.

Independent Director Presentations Advertisements Compliance Reports Stock Exchange Correspondence